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 (Pdzk1) , was determined in TPC, humeri, and kidneys at 24 
h. An in vitro  decrease in iPTH was seen in C3H and B6 TPC 
at 500 μ M (p < 0.001). In vivo levels of serum fluoride peaked 
at 0.5 h in both C3H (p = 0.002) and B6 (p = 0.01). In C3H, 
iPTH decreased at 24 h (p < 0.0001), returning to baseline at 
48 h. In B6, iPTH increased at 12 h (p < 0.001), returning to 
baseline at 24 h. Serum total calcium, phosphorus, and mag-
nesium levels did not change significantly.  Pth, Casr,  αKlotho, 
 Fgf1rc,  Vdr, and  Pthlh were significantly upregulated in C3H 
TPC compared to B6. In conclusion, the effects of fluoride on 
TPC in vitro were equivalent between the 2 mouse strains. 
However, fluoride demonstrated an early strain-dependent 
effect on iPTH secretion in vivo. Both strains demonstrated 
differences in the expression of genes involved in the BPK 
axis, suggesting a possible role in the physiologic handling 
of fluoride.  © 2015 S. Karger AG, Basel 
 Introduction 
 Fluoride has recognized actions on bone homeostasis 
[Everett, 2011]. Yan et al. [2007] investigated in 2 inbred 
strains of mice, C3H/HeJ (C3H) and C57BL/6J (B6), flu-
oride actions on bone homeostasis. In C3H mice, short-
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 Abstract 
 The study objective was to investigate the effects of fluoride 
on intact parathyroid hormone (iPTH) secretion. Thyro-
parathyroid complexes (TPC) from C3H (n = 18) and B6 (n = 
18) mice were cultured in Ca 2+ -optimized medium. TPC 
were treated with 0, 250, or 500 μ M NaF for 24 h and secret-
ed iPTH assayed by ELISA. C3H (n = 78) and B6 (n = 78) mice 
were gavaged once with distilled or fluoride (0.001 mg 
[F – ]/g of body weight) water. At serial time points (0.5–96 h) 
serum iPTH, fluoride, total calcium, phosphorus, and mag-
nesium levels were determined. Expression of genes in-
volved in mineral regulation via the bone-parathyroid-kid-
ney (BPK) axis, such as parathyroid hormone ( Pth), calcium-
sensing receptor  (Casr),  vitamin D receptor  (Vdr),  parathyroid 
hormone-like hormone  (Pthlh),  fibroblast growth factor 23 
 (Fgf23),  α-Klotho (αKlotho),  fibroblast growth factor receptor 
1c (Fgf1rc),  tumor necrosis factor 11  (Tnfs11),  parathyroid 
hormone receptor 1  (Pth1r),  solute carrier family 34 member 
1  (Slc34a1),  solute carrier 9 member 3 regulator 1  (Slc9a3r1), 
 chloride channel 5 (Clcn5), and PDZ domain-containing 1 
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term systemic exposure to fluoride resulted in increased 
osteoclastogenesis as evidenced by increases in the fol-
lowing serum osteoclast biomarkers: intact parathyroid 
hormone (iPTH), soluble receptor activator of nuclear 
factor-κB ligand (sRANKL), and tartrate-resistant acid 
phosphatase 5b (TRAP5b), along with a decrease in se-
rum osteoprotegerin levels [Yan et al., 2007]. Osteoclast 
numbers along bone surfaces and the osteoclast potential 
of bone marrow cells were increased in C3H mice as well. 
However, similar fluoride exposure in B6 mice favored 
anabolic responses, with increases in serum alkaline 
phosphatase activity and proximal tibia trabecular and 
vertebral bone mineral density.
 PTH is responsible for calcium homeostasis and is re-
leased in response to hypocalcemia to normalize serum 
calcium levels [Potts, 2005]. PTH is an important compo-
nent of the bone-parathyroid-kidney (BPK) feedback 
loop responsible for mineral homeostasis [Bergwitz and 
Juppner, 2010; Torres and De Brauwere, 2011]. Skeletal 
fluorosis results from systemic exposure to fluoride lead-
ing to calcification of ligaments, bone deformities, frac-
tures, functional limitations, a disturbed mineral balance, 
and occasional pseudo-hyperparathyroidism [Teotia and 
Teotia, 1973; Teotia et al., 1998]. The mechanisms under-
lying altered PTH levels due to fluoride exposure are not 
understood. We hypothesized that PTH secretion is in-
fluenced by direct effects of fluoride on the parathyroid 
gland. Our in vitro  and in vivo  experiments were directed 
to investigating early events following fluoride exposure 
on PTH secretion.
 Materials and Methods 
 Animals 
 Ninety-six 5- to 6-week-old male mice, C3H/HeJ (C3H) and 
C57BL/6J (B6) (The Jackson Laboratory, Bar Harbor, Maine, 
USA), were placed on a constant-nutrition no-fluoride diet [No. 
5861; Test Diet ® , Richmond, Ind., USA; fluoride: 0 ppm, calcium: 
0.60%, phosphorus: 0.57%, vitamin D 3 : 2.2 IU/g, and energy: 4.09 
(kcal/g) 2 ] and were provided with distilled drinking water ad libi-
tum for 1 week for acclimatization. The mice were housed in the 
Division of Lab Animal Medicine facility at The University of 
North Carolina at Chapel Hill, an AAALAC (Association for As-
sessment and Accreditation of Laboratory Animal Care Inter-
national)-accredited unit. Mice were placed in 12: 12-hour light-
dark cycles at a 21  °  C ambient temperature. All procedures involv-
ing vertebrate animals were approved by the Institutional Animal 
Care and Use Committee of The University of North Carolina at 
Chapel Hill.
 Parathyroid Gland Dispersed Cell Culture 
 Mice were euthanized using CO 2 , and ventral neck dissections 
were performed to isolate and harvest thyro-parathyroid complex-
es (TPC) after microdissections. TPC were finely minced and 
transferred to 2-ml centrifuge tubes with digestion buffer contain-
ing 1 mg/ml collagenase (Stem Cell Technologies, Vancouver, 
B.C., Canada) in dispase solution (Stem Cell Technologies). TPC 
were incubated at 37  °  C for 3 h with intermittent pipetting for ho-
mogeneous dispersion of cells. Dispersed cells were plated onto 
6-well plates and incubated at 37  °  C at 5% CO 2 in 2 ml prewarmed 
α-MEM (Sigma-Aldrich, St. Louis, Mo., USA) media with 10% FBS 
(Clontech Laboratories, Mountain View, Calif., USA) and 1% an-
tibiotic-antimycotic (Sigma-Aldrich). Total calcium, magnesium, 
and phosphorus levels in media were adjusted to that of the serum 
in each strain of mice as follows: C3H (calcium: 10.6 mg/dl, phos-
phorus: 8.7 mg/dl, and magnesium: 2.1 mg/dl) and B6 (calcium: 
10.4 mg/dl, phosphorus: 10.3 mg/dl, and magnesium: 2.9 mg/dl). 
TPC from C3H and B6 mice were prepared on 2 separate occasions 
using a total of 12 mice per strain. An initial study used 2 F con-
centrations (0 and 500 μ M ). This was repeated using additional 
mice, and 3 F concentrations were examined (0, 250, and 500 μ M ). 
Media supernatants were collected at 24 h, centrifuged, and stored 
at –80  °  C until analysis.
 Gavage and Sample Collections 
 Following acclimatization, 72 mice from both strains were ran-
domly divided in 12 groups of 6 mice (0.5, 1, 3, 6, 12, or 24 h) based 
on the time of sacrifice after the gavage dose, with control and test 
groups based on fluoride levels (0 or 100 ppm) in gavage. Addi-
tionally, 6 mice from both strains were assigned to the no-gavage-
at-baseline group. At the time of gavage, the mice were weighed 
and the gavage dose was calculated for each mouse (0.001 mg
[F – ]/g of body weight). Mice were anesthetized with ketamine-HCl 
(90 mg/kg) and xylazine (14 mg/kg) intraperitoneally. Sera were 





Casr calcium-sensing receptor 
Clcn5 chloride channel 5
Fgf1rc fibroblast growth factor receptor 1c
Fgf23 fibroblast growth factor 23
Gapdh glyceraldehyde 3-phosphate dehydrogenase
iPTH intact parathyroid hormone
Pdzk1 PDZ domain-containing 1
Pth parathyroid hormone 
Pth1r parathyroid hormone receptor 1
Pthlh parathyroid hormone-like hormone 
Slc34a1 solute carrier family 34 member 1 
Slc9a3r1 solute carrier 9 member 3 regulator 1
sRANKL soluble receptor activator of nuclear factor-κB ligand
Tnfs11 tumor necrosis factor 11
TPC thyro-parathyroid complex
Tpo thyroperoxidase
TRAP5b tartrate-resistant acid phosphatase 5b
Vdr vitamin D receptor 
αKlotho α-Klotho
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collected from anesthetized mice and stored at –80   °   C until use. 
TPC, kidneys, and humeri were harvested, snap-frozen in liquid 
nitrogen, and stored at –80  °  C.
 ELISA and Biochemistry Assays 
 Media supernatants and sera were analyzed for iPTH using 
1-84 PTH ELISA Kits (Immutopics, San Clemente, Calif., USA). 
The intra- and interassay precision (coefficient of variation) for the 
iPTH ELISA was 3.2 and 8.4, respectively. Each ELISA plate had 6 
standard and 2 control solutions for the determination of R 2 val-
ues. The threshold R 2 value was set at 0.95. All ELISA plates dem-
onstrated R 2 values >0.98. Each ELISA plate was read with 6 sam-
ples each from the control and test group in triplicates. 
 Serum levels of fluoride were determined using the direct fluo-
ride microanalysis method [Vogel et al., 1990]. In this method, 
micropipettes pulled from glass capillary tubes are combined with 
a custom-made micropipette holder and used to dispense nanoli-
ter-sized standards and serum samples (diluted 9: 1 with TISAB 
III). Serum samples are extracted over a light table using the mi-
cropipette/micropipette holder and dispensed onto the surface of 
an inverted fluoride electrode (F-ISE) under a layer of mineral oil 
to prevent loss of fluoride. Using a micromanipulator and a micro-
scope for viewing, the reference electrode is touched to the stan-
dard or sample drop, resulting in an electrometer millivolt reading. 
Both the F-ISE and the hand-pulled reference electrode are con-
nected to an electrometer and a computer with plot program mon-
itoring/recording software. Samples are run in triplicate, with pe-
riodic electrode conditioning and standard checks.
 Calcium, phosphorus, and magnesium levels were determined 
by the Animal Clinical Laboratory, University of North Carolina 
at Chapel Hill, and the Clinical Pathology Laboratory, College of 
Veterinary Medicine at North Carolina State University.
 RNA Extractions and cDNA Preparation 
 RNA was extracted from TPC, kidney, and humerus samples us-
ing an RNeasy Midi Kit (Qiagen Inc., Valencia, Calif., USA). Quan-
titative analysis of the RNA sample was performed using an Agilent 
Bioanalyzer with Nano LabChip at the Genomic Core Facility, Uni-
versity of North Carolina at Chapel Hill. All RNA samples had RIN 
values in the range of 7.5–10. A High-Capacity Reverse Transcrip-
tion Kit (Applied Biosciences, Carlsbad, Calif., USA) was used to 
prepare cDNA. After preparation, the cDNA was stored at –80  °  C.
 Quantitative Polymerase Chain Reaction 
 cDNA samples free of genomic DNA contamination were sub-
jected to quantitative polymerase chain reaction for a suite of genes 
including parathyroid hormone  (Pth), calcium-sensing receptor 
 (Casr), α-Klotho (α Klotho ), fibroblast growth factor receptor 1c 
 (Fgf1rc), vitamin D receptor  (Vdr), parathyroid hormone-like hor-
mone  (Pthlh), tumor necrosis factor 11  (Tnfs11), fibroblast growth 
factor 23  (Fgf23), parathyroid hormone receptor 1  (Pth1r), chlo-
ride channel 5  (Clcn5), solute carrier 9 member 3 regulator 1
 (Slc9a3r1), PDZ domain-containing 1  (Pdzk1), and solute carrier 
family 34 member 1  (Slc34a1). Expression of these genes was nor-
malized using 2 housekeeping genes comprising β-actin  (Actb) 
and glyceraldehyde 3-phosphate dehydrogenase  (Gapdh). Thyro-
peroxidase  (Tpo) was used as a surrogate marker for the quality of 
the TPC dispersed cell culture. All of the primers were from SA 
Biosciences (Qiagen). Data were analyzed using the 2 –ΔΔCt method 
[Livak and Schmittgen, 2001; Yuan et al., 2006].
 Statistical Analysis 
 Data are reported as means ± SE. One-way ANOVA was used 
to compare the effect of calcium concentration on iPTH secretion 
in the TPC dispersed cell culture model. For in vitro experiments, 
6 groups (each consisting of 6 mice) were compared using a 2-way 
ANOVA based on strain (C3H or B6) and the level of fluoride ex-
posure (0, 250, or 500 μ M ). For in vivo experiments, 24 groups were 
compared using a 3-way ANOVA based on strain (C3H or B6), the 
level of fluoride exposure (0 or 100 ppm), and time points (0.5, 1, 
3, 6, 12, and 24 h). A preliminary 2-way ANOVA was first used to 


















 Fig. 1. TPC histology and iPTH levels in supernatant media.  a His-
tological section of TPC; the arrow indicates parathyroid tissue.
 b iPTH ± SE in C3H TPC at 3 calcium concentrations (1.1, 10.5, 
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gavage (0 h) was included for both strains of mice (total n = 84), 
which would justify the omission of baseline gavage data at 0 h in 
order to maintain balance in the 3-way ANOVA. Three-way ANO-
VA were also evaluated for serum total calcium, phosphorus, and 
magnesium levels for each strain followed by treatment with 0 or 
100 μ M fluoride concentrations at 0.5, 1, 3, 6, 12, and 24 h. A natu-
ral log transformation was used for iPTH and serum fluoride (but 
not for calcium, magnesium, or phosphorus) to address skewness. 
ANOVA main effect and interaction p values  ≤ 0.05 were consid-
ered statistically significant, followed by Bonferroni adjustments 
for post hoc comparisons of levels of factors. SAS version 9.3 (SAS 
Inc., Cary, N.C., USA) was used for statistical analysis.
 Results 
 Responsiveness of the TPC Dispersed Cell
Culture Model 
 The TPC ( fig. 1 a) dispersed cell culture model was uti-
lized in order to determine the direct effects of fluoride 
on the parathyroid gland. All TPC dispersed cell cultures 
demonstrated  Tpo gene expression (a surrogate marker 
for TPC dispersed cell culture quality) with a Ct value of 
24.8 ± 2.1. The responsiveness of the dispersed cell cul-
ture model to changes in extracellular calcium, a known 
PTH mediator, was used to validate the culture model. 
TPC cultured in varying calcium concentrations (hypo-
calcemic: 1.1 mg/dl, normocalcemic: 10.5 mg/dl, or hy-
percalcemic: 25 mg/dl) demonstrated changes in iPTH 
secretion into the media (p < 0.001). Based on a Bonfer-
roni-corrected significance level of 0.05/3 = 0.017 and af-
ter 24 h of incubation in the hypocalcemic condition, 
iPTH secretion (129.4 ± 27.1 pg/ml) was significantly in-
creased (p = 0.007) compared to the normocalcemic con-
dition (49.2 ± 6.2 pg/ml) ( fig.  1 b). The hypercalcemic 
condition led to a further statistically significant decline 
in iPTH relative to the normocalcemic condition (p = 
0.012). Though not shown, TPC in culture remained re-
sponsive to changes in calcium for 3 days.
 Effect of Fluoride on TPC 
 The fluoride exposure experiments using TPC from 
B6 and C3H mice were performed at 2 different times. In 
an initial experiment, TPC from B6 (n = 6) and C3H (n = 
6) mice were cultured in media normalized to calcium, 
phosphorus, and magnesium levels present in the sera for 
each strain. Calcium, phosphorus, and magnesium are 
known modulators of iPTH and can serve as confounding 
variables and hence were kept at the levels commonly 
seen in the sera of each strain. Hence, constant levels of 
calcium, phosphorus, and magnesium were present in the 
test and control groups. This was followed by treatment 
with 2 fluoride concentrations (0 and 500 μ M ). Media su-
pernatants were collected at 24 h and iPTH levels were 
determined. TPC from C3H mice demonstrated a signif-
icant (p < 0.001) decrease in iPTH with increasing fluo-
ride concentrations from 0 μ M (145.7 ± 13.1 pg/ml) to 500 
μ M (72.2 ± 5.9 pg/ml). TPC from B6 mice demonstrated 
a similar decrease (p < 0.001) in iPTH with increasing 
fluoride concentrations from 0 μ M (88.3 ± 6.1 pg/ml) to 
500 μ M (47.1.1 ± 5.3 pg/ml). A replicate experiment was 
performed using TPC from B6 (n = 6) and C3H (n = 6) 
mice cultured in media normalized with calcium, phos-
phorus, and magnesium as described above and then fol-
lowed by treatment with varying fluoride concentrations 
(0, 250, and 500 μ M ). Media supernatants were collected 
at 24 h and iPTH levels were determined. In the 2-way 
ANOVA, main effects (both p < 0.001) and interaction
(p = 0.042) were statistically significant, indicating that 
iPTH differs significantly between the 2 strains and the 3 
fluoride levels, with the effect of fluoride exposure on 
iPTH being different for C3H versus B6. Based on a Bon-




















 Fig. 2. iPTH levels in supernatant media (in vitro study). Mean 
iPTH ± SE in C3H and B6 TPC after 24 h of incubation at 3 fluo-
ride concentrations (0, 250, and 500 μ M ; n = 6 in each group;
 * *  p < 0.005).  
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C3H, all 3 levels of fluoride exposure were significantly 
different from one another, with a higher fluoride level 
leading to a lower value of iPTH as follows: 0 μ M (128.5 ± 
10.6 pg/ml) to 250 μ M (86.2 ± 12.4 pg/ml, p < 0.001) or 
500 μ M (52.3 ± 8.9 pg/ml, p < 0.001). TPC from B6 mice 
demonstrated less of a decrease in iPTH with increasing 
fluoride concentrations from 0 μ M (64.3 ± 14.7 pg/ml) to 
250 μ M (50.9 ± 12.2 pg/ml) or 500 μ M (38.1 ± 5.1 pg/ml), 
with the only significant pairwise comparison relating to 
fluoride concentrations at 0 versus 500 μ M (p < 0.001) 
( fig. 2 ). In the initial and replicate studies, C3H had high-
er initial iPTH levels in the media compared to B6 TPC 
(p < 0.01). TPC from both strains showed F dose-depen-
dent decreases in iPTH secretion at 24 h. 
 Serum iPTH after a Single Fluoride Dose via 
Orogastric Gavage 
 As in the in vitro experiments, in vivo studies were 
done in two different instances. The initial experiment 
involved 42 mice per strain. Serum iPTH in C3H and B6 
mice was measured at 4 time points (baseline and 6, 12, 
and 24 h) after fluoride gavage (0.001 mg [F – ]/g of body 
weight) or gavage with an equal volume of 0 ppm fluoride 
water. At baseline with 0 ppm fluoride water gavage, the 
hour effect was not significant for main effect and inter-
action, and therefore the baseline observations were 
dropped from the analysis. The 3-way interaction be-
tween strain, hour, and gavage was not significant, but all 
2-way interactions were significant (strain × gavage: p = 
0.001, strain × hour: p < 0.001, gavage × hour: p = 0.009). 
Although significance was not reached, at 6 h after 100 
ppm fluoride gavage, serum iPTH levels increased mod-
estly for C3H (243.9 ± 13.4 pg/ml) and B6 (102.1 ± 7.3 pg/
ml) compared to baseline untreated levels (C3H: 210.5 ± 
16.2 pg/ml and B6: 86.6 ± 8.9 pg/ml) and control levels
(0 ppm fluoride gavage; C3H: 189.1 ± 19.8 pg/ml and B6: 
77.1 ± 4.8 pg/ml). In the C3H strain, iPTH dropped below 
baseline at 24 h (126.7 ± 10.2 pg/ml, p < 0.001) ( fig. 3 a), 
whereas in B6 iPTH increased at 12 h (234.8 ± 34.1 pg/ml, 
p < 0.001) after 100 ppm fluoride gavage ( fig. 3 b).
 The in vivo studies were replicated using an addition-
al 78 mice per strain. As before, serum iPTH was mea-
sured at various time points (0, 0.5, 1, 3, 6, 12, and 24 h) 
in C3H and B6 mice after fluoride gavage (0.001 mg
[F – ]/g body weight) or gavage with an equal volume of 0 



































 Fig. 3. Serum iPTH levels at 0, 6, 12, and 24 h. Mean serum iPTH ± SE after 0 or 100 ppm fluoride gavage in C3H 
( a ) and B6 ( b ) mice sacrificed at serial time points (0, 6, 12, and 24 h) compared to untreated mice (n = 6 in each 
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stricted to baseline gavage 0 μ M fluoride at 6 time points 
and strain as the second factor gave a nonsignificant in-
teraction and a nonsignificant time effect consistent with 
the assumption of no differences between the mean se-
rum iPTH for baseline gavage (0 h) and 0 μ M fluoride at 
any time point. In the 3-way ANOVA, the 3-way interac-
tion was not statistically significant, but all 2-way interac-
tions were significant (strain × gavage: p = 0.017, strain × 
hour: p < 0.001, gavage × hour: p < 0.001). This means 
that each factor has effects on iPTH that vary across the 
levels of a second factor when averaged over the third fac-
tor. Based on a Bonferroni-corrected significance level of 
0.05/6 = 0.008, fluoride levels of 0 and 100 ppm have a 
statistically different mean iPTH only at 0.5 h (p = 0.004) 
and 24 h (p < 0.0001) for either strain. Specifically, at
0.5 h, gavage with a fluoride level of 100 ppm yielded C3H 
(358.4 ± 19.4 pg/ml) and B6 [149.9 ± 21.2 pg/ml com-
pared to control (0 ppm fluoride gavage) levels (C3H: 
244.4 ± 35.5 pg/ml and B6: 98.6 ± 6.4 pg/ml)]. However, 
gavage with a fluoride level of 0 ppm yielded higher mean 
iPTH levels at 24 h (p  ≤ 0.001). In the C3H strain, iPTH 
dropped below baseline at 24 h (82.0 ± 10.7 pg/ml, p = 
0.002) ( fig.  4 a), whereas in B6, iPTH increased at 12 h 
(176.9 ± 20.8 pg/ml, p < 0.001) and then returned to base-
line at 24 h (95.6 ± 19.9 pg/ml) ( fig. 4 b). The peak iPTH 
value in C3H (358.4 ± 19.4 pg/ml) was twice the magni-
tude of the peak iPTH value in B6 (176.9 ± 20.8 pg/ml). 
 Since the iPTH levels in C3H mice dropped below 
baseline at 24 h, additional time points up to 96 h were 
examined. The serum iPTH in C3H mice after a single 
100-ppm fluoride gavage returned to baseline at 48 h 
( fig. 5 ). These data demonstrated a difference in the ef-
fects of fluoride on iPTH secretion in 2 mice strains: C3H 
and B6.
 Serum Fluoride Levels after Gavage 
 A calculated dose of fluoride was delivered by orogas-
tric gavage. Serum fluoride concentrations were mea-
sured at serial time points (0.5, 1, 3, 6, 12, and 24 h) after 
a single gavage dose. The fluoride levels in the serum 
peaked in both strains, i.e. C3H (61.0 ± 5.6 μ M ) and B6 
(26.7 ± 3.1 μ M ), 0.5 h (p < 0.001) after gavage. Fluoride 
levels reached baseline (0 ppm) in C3H (8.7 ± 1.7 μ M ) and 








































 Fig. 4. Serum iPTH levels at 0.5, 1, 3, 6, 12, and 24 h. Mean serum iPTH ± SE after 0 or 100 ppm fluoride gavage 
in C3H ( a ) and B6 ( b ) mice sacrificed at serial time points (0.5, 1, 3, 6, 12, and 24 h) compared to untreated mice 
(n = 6 in each group;  *  p < 0.05,  * *  p < 0.005). B = Baseline. 
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tween hour and strain was significant (p < 0.0001), indi-
cating that the pattern of fluoride kinetics is different 
across the strains. In particular, fluoride levels in B6 were 
significantly lower than in C3H at 0.5, 1, 3, and 12 h (p < 
0.001). The peak fluoride concentration in C3H (61.0 ± 
5.6 μ M ) was nearly twice that in B6 (26.7 ± 3.1 μ M ).
 Serum Total Calcium, Phosphorus, and
Magnesium Levels 
 Serum total calcium levels were relatively consistent 
between 0 and 100 ppm fluoride gavage in both C3H 
( fig. 7 a) and B6 mice ( fig. 7 d). We observed a significant 
reduction (p < 0.05) in serum total calcium only at 0.5 h 
in the 100 ppm fluoride gavage group (C3H: 8.7 ± 0.2 mg/
dl and B6: 8.5 ± 0.2 mg/dl) compared to the 0 ppm control 
(C3H: 8.9 ± 0.1 mg/dl and B6: 9.5 ± 0.2 mg/dl) and un-
treated baseline (C3H: 9.3 ± 0.1 mg/dl and B6: 9.2 ± 0.2 
mg/dl) groups.
 The strain × gavage interaction in the 2-way ANOVA 
for serum phosphorus levels was significant (p = 0.034). 
Hour was removed from the model as it was not statisti-
cally significant. Therefore, when time was not consid-
ered, there was an overall difference between 0 and 100 
ppm fluoride gavage for C3H (p = 0.009) ( fig. 7 b) but not 
for B6 ( fig. 7 e) mice. No statistically significant differenc-
es in magnesium levels were observed between 0 and 100 
ppm fluoride gavage at any time point for either C3H 
( fig. 7 c) or B6 ( fig. 7 f) mice.
 Quantitative Polymerase Chain Reaction: Expression 
of Genes Involved in the BPK Feedback Loop 
 We investigated the expression of various genes in-
volved in the BPK feedback loop using TPC, humeri, and 
kidneys. Expression of the genes in tissues obtained from 
100 ppm fluoride gavage C3H and B6 mice at 24 h were 
normalized with an average of 2 housekeeping genes 
 (Actb and  Gapdh). Gene expression was further normal-
ized to the control 0 ppm fluoride gavage group, and fold 
differences of genes in TPC ( fig. 8 a), humeri ( fig. 8 b),  and 
kidneys ( fig. 8 c) were calculated for C3H and B6 mice us-
ing the 2 –ΔΔCt method. In TPC,  Pth (p = 0.001),  Casr (p = 
0.012),  αKlotho (p = 0.003),  Fgf1rc  (p = 0.035),  Vdr (p = 
0.001), and  Pthlh (p = 0.03) were significantly upregu-



















 Fig. 5. Serum iPTH levels at 48–96 h. Mean serum iPTH ± SE (pg/
ml) after 0 or 100 ppm fluoride gavage in C3H mice harvested at 
extended time points (48, 72, and 96 h) compared to untreated 























 Fig. 6. Serum fluoride levels. Mean serum fluoride ± SE after 100 
ppm fluoride gavage in C3H and B6 mice sacrificed at serial time 
points (0.5, 1, 3, 6, 12, and 24 h) compared to baseline (no gavage) 



























































































(For legend see next page.)
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0.001) was significantly upregulated in C3H compared to 
B6 mice. In kidneys,  Pth1r (p = 0.005),  Clcn5 (p = 0.003), 
 αKlotho (p = 0.05),  Fgf1rc (p = 0.004), and  Slc9a3r1 (p = 
0.04) were significantly downregulated in C3H compared 
to B6.
 Discussion 
 Skeletal fluorosis is characterized by a spectrum of ra-
diographic bone changes ranging from osteoporosis to 
osteosclerosis [Wang et al., 1994]. Although clinical cases 
of skeletal fluorosis are rare in the USA [Kurland et al., 
2007; Whyte et al., 2008], in other parts of the world 
where skeletal fluorosis is more common, patients often 
demonstrate pseudo-hyperparathyroidism [Teotia and 
Teotia, 1973; Teotia et al., 1998; Gupta et al., 2001; Xu et 
al., 2010; Koroglu et al., 2011]. Epidemiologic studies 
have shown that individuals of a population exposed to 
similar fluoride levels demonstrate variable skeletal fea-
tures ranging from excessive bone formation to bone re-
sorption [Teotia et al., 1998; Harinarayan et al., 2006]. 
Therefore, the mechanisms that underlie the actions of 
fluoride on the bone and PTH are not clearly understood. 
Yan et al. [2007] demonstrated a link between fluoride 
exposure and iPTH levels using the C3H and B6 inbred 
strains of mice. Fluoride exposure in C3H led to enhanced 
osteoclastogenesis including elevated serum iPTH, 
whereas in B6 an anabolic action of fluoride was favored. 
Additionally, these strains are widely studied for their dif-
ferences in bone biology. C3H mice have a high bone 
mass, peak bone density, and alkaline phosphatase activ-
ity and a low bone resorption capacity compared to B6 
mice [Chen and Kalu, 1999; Linkhart et al., 1999; Turner 
et al., 2000, 2001]. 
 Direct or indirect effects of fluoride on the parathy-
roid gland have not been investigated. We developed a 
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 Fig. 7. Mean (±SE) serum calcium (Ca), phosphorus (P), and mag-
nesium (Mg) levels after 0 or 100 ppm fluoride gavage in C3H 
( a–c , respectively) and B6 ( d–f , respectively) mice harvested at
serial time points (0.5, 1, 3, 6, 12, and 24 h; n = 6 in each group;
 *  p < 0.05,  * *  p < 0.005). B = Baseline. 
 Fig. 8. Expression of genes involved in the BPK feedback loop. Fold 
difference ± SE in the C3H and B6 100-ppm fluoride gavage groups 
normalized to the control, the 0-ppm fluoride group, and the 
housekeeping gene pool  (Actb and  Gapdh) in TPC ( a ), humeri ( b ), 
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mouse strains with a predictable iPTH secretion response 
to changes in calcium. Similar TPC dispersed cell culture 
models have been employed using bovine, human, and 
rat parathyroid tissues to study parathyroid hormone 
regulation [Wongsurawat and Armbrecht, 1987; Nielsen 
et al., 1996; Nakajima et al., 2010]. Calcium, phosphorus, 
and magnesium are known to mediate changes in iPTH 
secretion and therefore the levels of these in the media 
were kept equivalent with strain-specific serum levels to 
prevent unwanted effects on iPTH secretion. In both 
C3H and B6, fluoride exposure resulted in dose-depen-
dent reductions in iPTH secretion into the media mea-
sured at 24 h. This reduction was more evident for C3H, 
which at baseline secretes almost twice the iPTH that B6 
does. 
 The fluoride kinetics observed for B6 and C3H strains 
were consistent with previous studies where serum fluo-
ride reached a peak within 20–30 min [Ekstrand et al., 
1977; Whitford, 1994]. It is generally accepted that after 
absorption fluoride is incorporated in newly mineral-
ized bone or is excreted in urine, resulting in a decline 
in serum levels, reaching baseline by 6–8 h [Ekstrand et 
al., 1980]. In order for fluoride to elicit a rapid iPTH re-
sponse, it is hypothesized that fluoride interacts with the 
parathyroid gland directly through modulation of iPTH 
release from vesicles in the chief cells. The exact molec-
ular mechanism of this response is not understood. 
However, our in vitro findings suggest the presence of 
such a direct interaction of fluoride on the parathyroid 
glands. 
 In the current study, C3H mice had higher baseline 
serum iPTH levels compared to B6 mice. This is consis-
tent with our TPC baseline values. C3H mice were more 
responsive to the single fluoride exposure, perhaps be-
cause they reached a higher peak serum fluoride level. 
This enhanced response was shown after the gavage when 
the levels of iPTH were higher in C3H compared to B6. 
At 24 h, iPTH levels were lower than baseline values for 
both strains. Both strains also showed bimodal responses 
to fluoride. For C3H, iPTH peaked at 0.5 h and declined 
below baseline at 12 h, reaching a nadir at 24 h, and then 
over the next 24 h it returned to baseline and remained at 
baseline at 96 h. B6 mice showed a similar but lower-mag-
nitude response.
 Modulation of iPTH secretion as a response to fluoride 
exposure may also be mediated by changes in calcium 
levels. Decreased serum calcium levels after acute hydro-
fluoric acid inhalation have been documented in humans 
[Zierold and Chauviere, 2012]. Acute exposure to fluo-
ride through injection of hydrofluoric acid (1.6 mg/kg) in 
rats led to a decrease in serum ionized calcium and total 
calcium after 30 and 300 min, respectively [Santoyo-San-
chez et al., 2013]. A similar decrease in plasma calcium 
has been observed in rats due to acute fluoride exposure 
[Imanishi et al., 2009]. The reduced serum calcium is hy-
pothesized to be due to the formation of CaF 2 complexes 
resulting in a net reduction in calcium levels leading to a 
hypocalcemic response. In our study, we observed a tran-
sient decrease in calcium in both strains of mice only at 
0.5 h, with a return to baseline within 1 h. There were no 
significant changes in phosphorus or magnesium at any 
time point.
 The BPK feedback loop has been extensively studied 
to understand the interaction of various genes involved 
in mineral homeostasis. The cross talk between bone, 
the parathyroid gland, and the kidney is responsible for 
effective regulation of minerals. The effect of fluoride 
on these individual tissues after a single fluoride dose in 
the 2 strains of mice will help us to understand the effect 
of fluoride on regulatory aspects of mineral homeosta-
sis. Changes in gene expression patterns due to fluoride 
exposure have been studied in the past [Li and Den-
Besten, 1993; Nair et al., 2011; Pei et al., 2012], but our 
study focused only on the expression of the genes that 
are involved in calcium and phosphorus homeostasis 
and are part of the BPK feedback loop. Fold differences 
in the expression of  Pth,  Casr,  αKlotho,  Fgf1rc,  Vdr,  and 
 Pthlh in TPC suggest that at the molecular level fluoride 
has a differential impact on parathyroid tissues in C3H 
and B6. The expression of these genes reflects a com-
pensatory mechanism to counter changes in iPTH se-
cretion. It is clear that fluoride effects are not limited to 
 Pth but extend to  Pth homologues such as  Pthlh. Ex-
pression of  Fgf1rc - αKlotho  (receptor couple for  Fgf23 ) 
 and Pth1r is suggestive of an effort to intercept conser-
vation of calcium and excretion of phosphorus in the 
kidneys to achieve homeostasis after the initial iPTH 
secretion. Overall, there exists a difference in expres-
sion of BPK genes in the 2 strains of mice. This suggests 
a difference in physiologic handling of fluoride by the 2 
strains. It will be interesting to study the effect of a re-
peated fluoride dose on expression of the key genes in 
C3H and B6.
 Our study investigated the early events involved in 
fluoride interaction on the parathyroid gland in vitro 
and in vivo. Fluoride can act on the parathyroid gland 
directly to modulate iPTH secretion in vitro and in vivo. 
It is still not clear if the decrease in total serum calcium 
levels is responsible for fluoride-mediated iPTH modu-
lation. The effect of fluoride on iPTH secretion is rapid 
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and observable even after a single fluoride dose. The 
overall effects of fluoride are not limited to the parathy-
roid gland, but changes in the expression of the genes 
involved in the BPK feedback loop suggest a broader 
impact of fluoride on multiple aspects of bone metabo-
lism.
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